Research map: Association between metabolic associated fatty liver disease (MAFLD) and non-alcoholic fatty pancreatic disease (NAFPD) among Egyptian patients

Back to the article

Papers in this map

  1. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement · Mohammed Eslam · 2020 · 4543 citations · Cited by this paper
  2. Studying serum immunoglobulin levels in metabolic dysfunction-associated steatotic liver disease · 2026 · Related
  3. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population · Giorgio Bedogni · 2006 · 3178 citations · Cited by this paper
  4. Direct acting antiviral drugs reduce CXCL10 gene expression and reverse metabolic dysfunction in chronic HCV-infected patients · 2025 · Related
  5. The Global Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among Patients With Type 2 Diabetes · Zobair M. Younossi · 2024 · 393 citations · Cited by this paper
  6. Role of serum FGF21 in the diagnosis of metabolic dysfunction–associated fatty liver disease: a case–control study of Egyptian patients · 2025 · Related
  7. Clinical implications of fatty pancreas: Correlations between fatty pancreas and metabolic syndrome · Jun Seok Lee · 2009 · 316 citations · Cited by this paper
  8. Exploring the role of peroxisome proliferator- activated receptor agonists (fenofibrate) in neonatal jaundice prevention · 2026 · Related
  9. Enigmatic Ectopic Fat: Prevalence of Nonalcoholic Fatty Pancreas Disease and Its Associated Factors in a Chinese Population · Chih‐Yuan Wang · 2014 · 213 citations · Cited by this paper
  10. Adjuvant anti-PD-L1 therapy for hepatocellular carcinoma following curative treatment: case series · 2026 · Related
  11. NAFLD fibrosis score: A prognostic predictor for mortality and liver complications among NAFLD patients · Sombat Treeprasertsuk · 2013 · 204 citations · Cited by this paper
  12. Value and accuracy of pro-calcitonin versus C-reactive protein in diagnosis of bacterial infection in cirrhotic patients · 2026 · Related
  13. Incidence and diagnostic significance of minor pathologic changes in the adult pancreas at autopsy: · Bernhard Stamm · 1984 · 192 citations · Cited by this paper
  14. Evaluation of serum Apurinic/Apyrimidinic Endodeoxyribonuclease 1 (APEX1) Level in cholangiocarcinoma and hepatocellular carcinoma patients · 2026 · Related
  15. A prospective evaluation of fatty pancreas by using EUS · Paul S. Sepe · 2011 · 185 citations · Cited by this paper
  16. Serum dipeptidyl peptidase-4 in chronic liver disease patients with osteoporosis · 2026 · Related
  17. Lipomatosis of the Pancreas In Autopsy Material and Its Relation to Age And Overweight · Tom Skyhøj Olsen · 1978 · 174 citations · Cited by this paper
  18. Potential association between PNPLA3 rs738409 and hepatocellular carcinoma in Egyptian patients with type 2 diabetes mellitus · 2026 · Related
  19. Association between non-alcoholic fatty pancreatic disease (nafpd) and the metabolic syndrome: case–control retrospective study · Wan-Chen Wu · 2013 · 157 citations · Cited by this paper
  20. An assessment of treatment outcomes among hepatocellular carcinoma patients at Kenyatta National Hospital · 2026 · Related
  21. Low levels of physical activity are associated with dysregulation of energy intake and fat mass gain over 1 year · Robin P. Shook · 2015 · 157 citations · Cited by this paper
  22. The Role of “Fatty Pancreas” and of BMI in the Occurrence of Pancreatic Fistula After Pancreaticoduodenectomy · Edoardo Rosso · 2009 · 146 citations · Cited by this paper
  23. Predictors of Ectopic Fat Accumulation in Liver and Pancreas in Obese Men and Women · Andrea Petronio Rossi · 2011 · 127 citations · Cited by this paper
  24. The correlation between pancreatic steatosis and metabolic syndrome in a Chinese population · Jie Zhou · 2016 · 106 citations · Cited by this paper
  25. Relationships between serum total bilirubin levels and metabolic syndrome in Korean adults · Seung Ho Choi · 2011 · 105 citations · Cited by this paper
  26. Metabolic Dysfunction‐Associated Steatotic Liver Disease ( MASLD ): Mechanisms, Clinical Implications and Therapeutic Advances · Dalia M. Miller · 2025 · 89 citations · Cited by this paper
  27. The effect of fatty pancreas on serum glucose parameters in patients with nonalcoholic steatohepatitis · Ahmet Uygun · 2014 · 87 citations · Cited by this paper
  28. Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: Current Issues and Future Perspectives in Preclinical and Clinical Research · Clarissa Berardo · 2020 · 81 citations · Cited by this paper
  29. Fatty Pancreas Is Independently Associated With Subsequent Diabetes Mellitus Development: A 10-Year Prospective Cohort Study · Ting Ting Chan · 2021 · 77 citations · Cited by this paper
  30. Prevalence and factors associated with nonalcoholic fatty pancreas disease and its severity in China · Siying Weng · 2018 · 73 citations · Cited by this paper
  31. The association between pancreas steatosis and metabolic syndrome: A systematic review and meta‐analysis · Ye Bi · 2019 · 71 citations · Cited by this paper
  32. Nonalcoholic Fatty Pancreas Disease: Clinical Consequences · Petr Dítě · 2019 · 69 citations · Cited by this paper
  33. Non-alcoholic Fatty Liver Disease, Metabolic syndrome, and Type 2 diabetes mellitus: Where do we stand today? · Bojan Mitrovic · 2022 · 66 citations · Cited by this paper
  34. Pancreatic fat accumulation and its relationship with liver fat content and other fat depots in obese individuals. · Giovanni Targher · 2012 · 53 citations · Cited by this paper
  35. TLR9 regulates adipose tissue inflammation and obesity-related metabolic disorders · Chun‐Pyo Hong · 2015 · 50 citations · Cited by this paper
  36. Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease · Lucia Pacifico · 2015 · 48 citations · Cited by this paper
  37. The Effect and Mechanism of TLR9/KLF4 in FFA-Induced Adipocyte Inflammation · Cuizhe Wang · 2018 · 48 citations · Cited by this paper
  38. Prevalence and clinical characteristics of fatty pancreas in Yangzhou, China: A cross-sectional study · Dan Wang · 2018 · 47 citations · Cited by this paper
  39. Pancreatic steatosis and metabolic pancreatic disease: a new entity? · Federico Caldart · 2023 · 44 citations · Cited by this paper

Source: OpenAlex (CC0)